Receptor activator of nuclear factor kappa-B (RANK) is a crucial protein involved in the regulation of bone metabolism, immune response, and lymph node development by acting as a receptor for RANK ligand (RANKL). Its activation leads to osteoclast differentiation and activation, making it a target for therapeutic interventions in conditions like osteoporosis and cancer-induced bone diseases.